EP 1414479 A4 20050713 - PEPTIDE FOR REGULATION OF TISSUE PLASMINOGEN ACTIVATOR
Title (en)
PEPTIDE FOR REGULATION OF TISSUE PLASMINOGEN ACTIVATOR
Title (de)
PEPTID ZUR REGULIERUNG DES GEWEBEPLASMINOGENAKTIVATORS
Title (fr)
PEPTIDE DESTINE A LA REGULATION DE L'ACTIVATEUR TISSULAIRE DU PLASMINOGENE
Publication
Application
Priority
- US 0220077 W 20020624
- US 90213501 A 20010710
Abstract (en)
[origin: WO03006042A1] The present invention relates to the polypeptide, the use of the polypeptide in the prevention and/or treatment of side effects induced by plasminogen activators, specifically tPA or uPA. The invention further relates to combination compositions and/or therapy regimens, comprising the polypeptide and one or more currently used plasminogen activators, and methods to achieve improved fibrinolytic efficacy as well as reducing their side effects.
IPC 1-7
IPC 8 full level
A61K 9/20 (2006.01); A61K 38/00 (2006.01); A61K 38/43 (2006.01); A61K 38/49 (2006.01); A61K 38/57 (2006.01); A61K 45/00 (2006.01); A61P 7/02 (2006.01); C07K 7/06 (2006.01)
CPC (source: EP KR)
A61K 38/49 (2013.01 - EP); A61K 38/57 (2013.01 - EP); A61P 7/02 (2017.12 - EP); C07K 7/06 (2013.01 - EP); H05B 7/22 (2013.01 - KR)
C-Set (source: EP)
Citation (search report)
- No further relevant documents disclosed
- See references of WO 03006042A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03006042 A1 20030123; BR PI0211234 B1 20180403; CA 2453309 A1 20030123; EP 1414479 A1 20040506; EP 1414479 A4 20050713; JP 2004534842 A 20041118; KR 20040018442 A 20040303
DOCDB simple family (application)
US 0220077 W 20020624; BR PI0211234 A 20020710; CA 2453309 A 20020624; EP 02752090 A 20020624; JP 2003511848 A 20020624; KR 20047000327 A 20020710